University of Tübingen

EQS-News: Cautious growth: SHS Medical Technology Index grows slightly in second year of Corona crisis

Retrieved on: 
Sunday, January 22, 2023

The SHS Medical Technology Index has returned to growth mode in the second year of the pandemic, albeit modestly.

Key Points: 
  • The SHS Medical Technology Index has returned to growth mode in the second year of the pandemic, albeit modestly.
  • The SHS Medical Technology Index, which was compiled for the first time in 2019, tracks the growth capacity, innovative strength and economic performance of the medical technology sector since 2010 in comparison to the economy as a whole.
  • The slight overall increase in the medical technology index is due to several factors that are included in the index calculation.
  • The SHS Medical Technology Index was developed by SHS Gesellschaft für Beteiligungsmanagement in cooperation with Professor Dr Christian Koziol of the Eberhard Karls University in Tübingen.

DGAP-News: SHS appoints Manfred Ulmer-Weber to the Management Board

Retrieved on: 
Thursday, August 18, 2022

Manfred Ulmer-Weber has been appointed to the management board of SHS Gesellschaft fr Beteiligungsmanagement mbH.

Key Points: 
  • Manfred Ulmer-Weber has been appointed to the management board of SHS Gesellschaft fr Beteiligungsmanagement mbH.
  • The shareholders of SHS Gesellschaft fr Beteiligungsmanagement mbH have appointed Manfred Ulmer-Weber as an additional Managing Director as of 15 July 2022.
  • Manfred holds board and shareholder positions for SHS Funds, for example at the fast-growing portfolio companies Develco Pharma Schweiz AG, TRI Dental Implants Int.
  • The national and international investors in SHS funds include pension funds, funds of funds, foundations, family offices, strategic investors, entrepreneurs and the SHS management team.

Christian Silies Joins Sompo International’s Reinsurance Business as Head of Global Marine and Energy

Retrieved on: 
Monday, March 21, 2022

PEMBROKE, Bermuda, March 21, 2022 (GLOBE NEWSWIRE) -- Sompo International, a leading global provider of commercial and consumer property and casualty (re)insurance,announced today that Mr. Christian Silies has joined the companys Reinsurance platform as Head of Global Marine and Energy.

Key Points: 
  • PEMBROKE, Bermuda, March 21, 2022 (GLOBE NEWSWIRE) -- Sompo International, a leading global provider of commercial and consumer property and casualty (re)insurance,announced today that Mr. Christian Silies has joined the companys Reinsurance platform as Head of Global Marine and Energy.
  • Mr. Donelan commented, With a proven track record of successfully building out global marine and energy reinsurance capabilities, Christian will be a great asset and we are pleased that he has joined Sompo International.
  • He joins Sompo International from AON Reinsurance Solutions in London, where he served as Head of Marine & Energy Composite and was a Member their Global Re Specialty Management Team and UK Reinsurance Executive Team.
  • Mr. Silies added, Having partnered with this exceptional Global Marine & Energy Reinsurance team, I am excited to join this best-in-class organization.

InfanDx AG: Clinical Findings from Prospective AAMBI Study Highlight Need for Better Early Detection of Neonatal Brain Injury

Retrieved on: 
Thursday, February 10, 2022

The data highlight the need for novel reliable biomarkers for the early detection of Hypoxic-Ischemic Encephalopathy (HIE), i.e., neural injury caused by oxygen deprivation around the time of birth (perinatal asphyxia).

Key Points: 
  • The data highlight the need for novel reliable biomarkers for the early detection of Hypoxic-Ischemic Encephalopathy (HIE), i.e., neural injury caused by oxygen deprivation around the time of birth (perinatal asphyxia).
  • The AAMBI study was conducted as a prospective observational trial at four neonatal centers in Turkey.
  • The neonatal short-term clinical outcome was determined for 144 surviving children based on further clinical assessment, cerebral MRI and amplitude-integrated EEG (aEEG).
  • Building on AAMBI and further clinical studies, InfanDx is developing the HypoxE Test for the detection of early biomarkers for HIE in blood.

BioFlux System Used in Key Studies to Identify Causes and Treatments of Blood Clots Related to COVID-19

Retrieved on: 
Thursday, January 27, 2022

Although predominantly a respiratory disease, COVID-19 has been shown to cause a range of responses, including adverse effects on the cardiovascular system.

Key Points: 
  • Although predominantly a respiratory disease, COVID-19 has been shown to cause a range of responses, including adverse effects on the cardiovascular system.
  • Both papers relied on the BioFlux system to assess platelet function in COVID-19 patients.
  • Used in more than 500 labs globally, the BioFlux system is available in a variety of configurations to meet the application requirements of any laboratory.
  • Systems are available with a range of capabilities and throughputs and are used in basic research through drug discovery and diagnostic development.

DGAP-News: Stability: SHS Medical Technology Index holds its own in the crisis

Retrieved on: 
Tuesday, December 21, 2021

The SHS Medical Technology Index, which is being compiled for the first time in 2019, tracks the growth capacity, innovative strength and economic performance of the medical technology sector since 2010 in comparison with the economy as a whole.

Key Points: 
  • The SHS Medical Technology Index, which is being compiled for the first time in 2019, tracks the growth capacity, innovative strength and economic performance of the medical technology sector since 2010 in comparison with the economy as a whole.
  • The decline in the medical technology index is due to several factors that are included in the index calculation.
  • For the current year 2021, the creators of the SHS Medical Technology Index are cautiously optimistic and continue to expect a better performance of the medical technology sector compared to the overall economy.
  • The SHS Medical Technology Index was developed by SHS Gesellschaft fr Beteiligungsmanagement in cooperation with Professor Dr. Christian Koziol from Eberhard Karls University in Tbingen.